[Cancer en cuirasse, induced by a malignant mixed salivary gland tumor].
A case of cancer en cuirasse is reported, deriving from a metastasizing malignant mixed tumor of the lacrimal gland. Based on histological criteria, the primary benigne prognosis of mixed tumors of lacrimal glands is discussed. According to sensitivity testing to cytostatic agents treatment with 375 mg of bleomycin achieved a recurrence-free interval of eight months. Pathogenesis of secondary effects are discussed (so-drug-induced called bleomycin-lung).
D008949:Adenoma, Pleomorphic / Q000473:pathology*; D001761:Bleomycin / Q000627:therapeutic use; D003907:Dexamethasone / Q000627:therapeutic use; D004359:Drug Therapy, Combination; D006493:Heparin / Q000627:therapeutic use; D006801:Humans; D008297:Male; D008875:Middle Aged; D009362:Neoplasm Metastasis; D010178:Pancoast Syndrome / Q000188:drug therapy / Q000473:pathology*; D012468:Salivary Gland Neoplasms / Q000473:pathology*
D001761:Bleomycin; D003907:Dexamethasone; D006493:Heparin
Cancer en cuirasse, induziert durch einen malignen Tränendrüsenmischtumor.